Compare GSK plc (GSK) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Snap Inc — how do they compare? GSK plc trades at $50.58 (market cap $104.15B), while Snap Inc trades at $5.49 (market cap $9.05B). The key difference: GSK plc is far larger — about 11.5× Snap Inc's market cap, and GSK plc pays a 3.48% dividend while Snap Inc pays none. Which is the better fit depends on your goals.
| GSK | SNAP | |
|---|---|---|
Market Cap | $104.15B | $9.05B |
Sector | Health | Media |
52-Week High | $61.18 | $9.09 |
52-Week Low | $38.22 | $3.93 |
Enterprise Value | $124.56B | $10.61B |
Dividend Yield | 3.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
